Table 5.
Broad-spectrum antibiotic prescriptions for all clinical pathway conditions
| Study Group | Control Group | |||||
|---|---|---|---|---|---|---|
|
| ||||||
| Baseline period | Intervention period | P | Baseline period | Intervention period | P | |
| N = 21351 | N = 11619 | N = 10017 | N = 5403 | |||
| Broad-spectrum antibiotic prescribed | 5645 (26.4) | 2630 (22.6) | <.0001 | 2004 (20.0) | 1047 (19.4) | 0.35 |
| Upper respiratory infection | 771 (14.7) | 272 (9.0) | 216 (7.5) | 116 (9.1) | ||
| Acute bronchitis | 1333 (45.5) | 524 (39.1) | 506 (46.3) | 228 (40.3) | ||
| Pharyngitis | 337 (14.1) | 153 (11.3) | 150 (10.8) | 96 (9.8) | ||
| Acute rhinosinusitis | 1429 (42.4) | 646 (40.2) | 506 (35.5) | 274 (34.4) | ||
| Acute otitis media | 333 (28.3) | 171 (29.2) | 152 (18.0) | 77 (17.8) | ||
| Urinary tract infection | 963 (29.2) | 641 (32.7) | 280 (24.3) | 119 (19.2) | ||
| Skin and soft tissue infection | 283 (13.3) | 143 (10.6) | 101 (11.9) | 70 (13.5) | ||
| Pneumonia | 196 (24.2) | 80 (19.1) | 93 (25.5) | 67 (31.8) | ||
*
Denominator for individual conditions is the number of cases of each condition from Table 3.